Keynote lecture

Iannis Aifantis (NYU Langone Health, New York, USA)

Inflammation and its role in the regulation of healthy and neoplastic hematopoiesis

​

Invited Speakers

 - Katrin Ottersbach (The University of Edinburgh, UK)

Understanding the unique biology of leukaemia in infants

​

- Catherine Robin (Hubrecht Institute, Netherlands)

Building the blood system: developmental origins and regulation of hematopoietic stem cells and macrophages

​

- Panagiotis Ntziachristos (Ghent University, Belgium)

Characterizing and targeting RNA dysregulation in acute leukemia

​

- Betty Gardie (Institut du thorax, Nantes, France)

Study of hypoxia genes associated with hereditary erythrocytosis

​

- Jean Soulier (Saint Louis Research Institute, Paris, France)

Genomic instability and HSC attrition as a preleukemia condition​​

​

- Yaara Oren (Tel Aviv University, Israel)

Raising from the ashes of treatment - understanding and targeting cancer persister cells

​

- Olivier Kosmider (Cochin Hospital, Paris, France)

Inflammation in hematological disorders : what do we learn from VEXAS syndrome?

 

- Emma De Pater (Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands)

Mutations in GATA2; defective hematopoiesis and malignant transformation

 

 

Young PI session

 - Valéria Bisio (Saint-Louis Institute, Paris, France).

Unraveling Immune Interactions in Myelodysplastic Syndromes: Focus on Natural Killer Lymphocytes and Mesenchymal Stromal Cells

 

- Brahim Arkoun (IGR, Villejuif, France).

iPS cells as a tool for modeling Down syndrome–associated AMKL and optimizing ex vivo platelet production

 

- Raphaël Leblanc (CRCM, Marseille, France).

Dissecting and targeting extracellular vesicle-mediated communication in TP53-mutated acute myeloid leukemia